Fragrant snow pharmaceutical trapped in the false storm supplier drug qualification has been withdrawn

For the Guangdong pharmaceutical falsely open value-added tax invoices report material inadvertently but will fragrant snow pharmacy pulled down the horse. Yesterday, following the reported material refers to the alleged virtual increase in performance, after the fake listing, there are pharmaceutical industry people to the south of the reporter reported that the largest supplier of incense, snow pharmaceutical in recent years, that is, the report material mentioned in the health of the "Pharmaceutical Management Standard Certification" (hereinafter referred to as the drug GSP certificate) has been the Drug Administration department to recover. Affected by the recent negative impact, fragrant snow pharmaceutical stocks had been forced to suspend business yesterday afternoon, its securities department in charge of the reporters interviewed by the south have no comment, said only that the company will be issued to clarify the announcement of the relevant instructions. However, until the reporter 10 o'clock last evening deadline, no relevant clarification notice was found. Financial fraud caused by the fermentation of incense snow is suspected of a virtual increase in the performance, false listing shadow of the report material, its clues first appeared in some of the domestic web site bar. As early as in May, Baidu posted in that someone burst the material, Guangzhou Jian an Tang Pharmaceutical Co., Ltd. boss Shelifa suspected falsely open value-added tax invoices, the report post is now fragrant snow pharmaceutical figure. The May 13 report on the public media directly led to the problem. Media reports said that at the end of 2007 to enter the general manager of Guangdong Pharmaceutical Yong Yong, general manager of the original Shannon Snow, last April 25, because of complicity with others embezzled company assets were arrested, which led to the health of the church for a number of companies falsely open value-added tax invoices, fragrant snow pharmaceutical also involved in it. The news comes after the two days of fragrant snow pharmaceutical stock price volatility. Investor Relations on the platform, as early as June 13, there are investors asked about the explosion of fragrant snow pharmaceutical vat problem. However, the two-tier market has not seen a clarification notice. Yesterday, this big bad also became the fragrant Snow pharmacy temporary shareholder meeting the investor general attention question, however, the fragrant Snow pharmacy management did not give the reply directly, said that will announce in the evening of June 14 The clarification announcement to explain the question one by one. At yesterday's shareholder meeting, prior to being referred to the premium of the fragrant snow pharmaceutical "on the acquisition of Bozhou Shanghai Qiao Pharmaceutical Co., Ltd. 70% stake in the bill passed, but from the capital markets, the news that some investors have to Shenzhen and Guangdong Securities and Regulatory Bureau to report on the alleged virtual increase in performance, fake listing problems." Jian an Tang GSP qualification was once withdrawn close to the health church in Guangzhou, the senior pharmaceutical industry yesterday to the south of the report that the health Care Hall GSP certificate was once the Guangdong Food and Drug Administration revoked. Yesterday, the south of the press to call the health of the church in the sale of value-added tax invoices and GSP certificate has been revoked, the company declined to disclose the identity of the respondents to ask why the reporter raised this issue, and "no relevant responsible for the phone" as a reason to refuse to further respond to this matter. The reporter then to Guangdong Province Food and Drug Administration to verify. However, the head of the bureau's office did not give a positive or negative response, saying that further inquiries were required. Data from the State administration of Food and Drug Administration GSP certification database shows that the drug GSP of Guangzhou Jian an Tang Pharmaceutical Co., Ltd.Certificate (number a-gd-12-0086) was not certified until September 26, 2012. But its previously numbered a-gd-09-0209 drug GSP certificate was revoked on July 31, 2012. Guangdong Province Food and Drug Administration announced that the result of its GSP qualification was removed because of "serious violations of the drug management and quality management norms" and "Guangdong Province pharmaceutical Wholesale Enterprises GSP certification Site Inspection Project table (trial)" provisions. It is noteworthy that the fragrant Snow Pharmaceutical 2011, 2010 Annual report shows, "Canton Jian an Tang Pharmaceutical Co., Ltd." is the largest supplier of fragrant snow pharmaceutical. The two years of fragrant snow pharmaceutical and the company completed the purchase amount of up to 36.166 million yuan and 33.2453 million yuan respectively. The annual report also shows that 2011 fragrant snow pharmaceutical Industry and "Guangzhou Jian an Tang Pharmaceutical Co., Ltd." signed the inclusion of Shanxi Forsythia, Guizhou Calamus, Henan Rehmannia, Hebei rhizome, Guangdong Patchouli, such as the "Material purchase contract" big single. and the above medicinal herbs mostly for the main products of the anti-viral oral liquid.